CAR-NK Targeted CD19 for r/r B-cell Malignancies

NCT05645601 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Adult Relapsed/Refractory B-cell Hematologic Malignancies

Interventions

BIOLOGICAL: CD19-CAR-NK

Sponsor

Affiliated Hospital to Academy of Military Medical Sciences

Collaborators

[object Object]